The FDA cited a Mylan Pharmaceuticals facility for massive quality control problems and inadequate data integrity. Read More
The FDA flagged API manufacturer Emcure Pharmaceuticals, citing inadequate validation, testing and reporting. Read More
The FDA identified several issues with record-keeping. Read More
The FDA has cited four device firms for a range of compliance issues including inadequate complaint procedures. Read More
The FDA cited an Indoco Remedies API facility in Goa, India, for serious quality failures and inadequate handling of complaints. Read More
300 N Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 – Fax (703) 538-7676 – Toll free (888) 838-5578.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing